BEAM logo

Beam Therapeutics (BEAM) Shareholders equity

annual shareholders equity:

$733.54M-$247.78M(-25.25%)
December 31, 2024

Summary

  • As of today (July 4, 2025), BEAM annual stockholders equity is $733.54 million, with the most recent change of -$247.78 million (-25.25%) on December 31, 2024.
  • During the last 3 years, BEAM annual shareholders equity has fallen by -$93.19 million (-11.27%).
  • BEAM annual shareholders equity is now -25.25% below its all-time high of $981.33 million, reached on December 31, 2023.

Performance

BEAM Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMbalance sheet metrics

quarterly shareholders equity:

$1.12B+$389.59M(+53.11%)
March 31, 2025

Summary

  • As of today (July 4, 2025), BEAM quarterly stockholders equity is $1.12 billion, with the most recent change of +$389.59 million (+53.11%) on March 31, 2025.
  • Over the past year, BEAM quarterly shareholders equity has increased by +$209.65 million (+22.95%).
  • BEAM quarterly shareholders equity is now at all-time high.

Performance

BEAM quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

BEAM Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.3%+22.9%
3 y3 years-11.3%+35.5%
5 y5 years+626.7%+329.7%

BEAM Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.3%+0.0%at high+57.2%
5 y5-year-25.3%+626.7%at high+461.4%
alltimeall time-25.3%>+9999.0%at high+1012.6%

BEAM Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$1.12B(+53.1%)
Dec 2024
$733.54M(-25.2%)
$733.54M(-7.3%)
Sep 2024
-
$791.32M(-7.4%)
Jun 2024
-
$854.09M(-6.5%)
Mar 2024
-
$913.49M(-6.9%)
Dec 2023
$981.33M(+33.8%)
$981.33M(+26.0%)
Sep 2023
-
$778.94M(-4.0%)
Jun 2023
-
$811.64M(+6.6%)
Mar 2023
-
$761.51M(+3.8%)
Dec 2022
$733.47M(-11.3%)
$733.47M(+2.7%)
Sep 2022
-
$714.48M(-10.7%)
Jun 2022
-
$800.16M(-3.5%)
Mar 2022
-
$829.07M(+0.3%)
DateAnnualQuarterly
Dec 2021
$826.74M(+236.7%)
$826.74M(-3.2%)
Sep 2021
-
$853.81M(+55.6%)
Jun 2021
-
$548.55M(+29.9%)
Mar 2021
-
$422.43M(+72.0%)
Dec 2020
$245.56M(+143.3%)
$245.56M(+22.7%)
Sep 2020
-
$200.07M(-13.3%)
Jun 2020
-
$230.82M(-11.7%)
Mar 2020
-
$261.39M(+158.9%)
Dec 2019
$100.94M(-24.7%)
$100.94M(-20.3%)
Sep 2019
-
$126.72M(-11.8%)
Jun 2019
-
$143.65M(+7.2%)
Dec 2018
$134.03M(-3304.1%)
$134.03M
Dec 2017
-$4.18M
-

FAQ

  • What is Beam Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Beam Therapeutics?
  • What is Beam Therapeutics annual shareholders equity year-on-year change?
  • What is Beam Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Beam Therapeutics?
  • What is Beam Therapeutics quarterly shareholders equity year-on-year change?

What is Beam Therapeutics annual stockholders equity?

The current annual shareholders equity of BEAM is $733.54M

What is the all time high annual shareholders equity for Beam Therapeutics?

Beam Therapeutics all-time high annual stockholders equity is $981.33M

What is Beam Therapeutics annual shareholders equity year-on-year change?

Over the past year, BEAM annual stockholders equity has changed by -$247.78M (-25.25%)

What is Beam Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of BEAM is $1.12B

What is the all time high quarterly shareholders equity for Beam Therapeutics?

Beam Therapeutics all-time high quarterly stockholders equity is $1.12B

What is Beam Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, BEAM quarterly stockholders equity has changed by +$209.65M (+22.95%)
On this page